Uncommon Manifestation of Oligometastatic Prostate Cancer: Sister Mary Joseph Nodule

Clin Nucl Med. 2023 May 1;48(5):e225-e227. doi: 10.1097/RLU.0000000000004614. Epub 2023 Mar 6.

Abstract

A 76-year-old man with a history of prostate cancer diagnosed in 2008 developed biochemical recurrence in 2010 and started intermittent androgen deprivation therapy. In 2021, due to rising prostate-specific antigen, an 18 F-piflufolastat PSMA PET/CT was performed. It showed a radiotracer-avid sclerotic lesion in the right iliac bone and an indeterminate radiotracer-avid nodule in the umbilical region, demonstrating progressive enlargement and increased uptake on subsequent imaging. Pathologic analysis of the umbilical nodule revealed metastatic prostate cancer-a finding eponymically referred to as a Sister Mary Joseph nodule.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Androgen Antagonists
  • Humans
  • Male
  • Positron Emission Tomography Computed Tomography / methods
  • Prostate-Specific Antigen
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / pathology
  • Radiopharmaceuticals
  • Sister Mary Joseph's Nodule* / diagnostic imaging
  • Sister Mary Joseph's Nodule* / secondary

Substances

  • Androgen Antagonists
  • Prostate-Specific Antigen
  • Radiopharmaceuticals